United States · FDA National Drug Code directory
CX-038839 OMICRON (XBB.1.5)
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 84586-001_312cfb9a-5193-8b4a-e063-6394a90a8aeb
- Product NDC
- 84586-001
- Form
- INJECTION, SUSPENSION
- Composition / generic term
- CX-038839 OMICRON (XBB.1.5)
- Labeler
- Alloga Logstica Espaa S.L.
- Marketing category
- DRUG FOR FURTHER PROCESSING
- Marketing start / end (source format)
- 20230911
- Source listing expiry
- 20261231
Source-listed ingredients
- CX-038839 OMICRON (XBB.1.5) — 50 ug/.5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 SYRINGE, PLASTIC in 1 CARTON (84586-001-01) / .5 mL in 1 SYRINGE, PLASTIC (84586-001-00) · 84586-001-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →